Term
|
Definition
MOA: These drugs block the fast sodium channels in the myocardium. They show intermediate dissociation from the sodium channels and lengthen the refractory period to stop the arrhythmia. The sodium channel is responsible for depolarization in the myocardium |
|
|
Term
|
Definition
Quinidine
Procainamide (Prontestyl®)
Disopyramide (Norpace®) |
|
|
Term
|
Definition
No brand name
Used to treat supraventricular and ventricular arrhythmias
80% bound to protein
SE: Thrombocytopenia
One of the first antiarrhythmics and is still used today
Class IA |
|
|
Term
|
Definition
Pronestyl®
Used mainly for ventricular arrhythmias
Metabolized by N-acetyl transferase to N-acetylprocainamide, 50% is excrete unchanged in the urine
SE: Systemic Lupus erythamatous (SLE) like syndrome
Class IA |
|
|
Term
|
Definition
Norpace®
Used primarily to prevent ventricular tachycardia and premature ventricular contractions
Half life=6.7 hours
SE: Has anticholinergic side effects
Class IA |
|
|
Term
|
Definition
MOA: Blocks the fast sodium channels. Dissociate rapidly from the sodium channel and have the lowest potency |
|
|
Term
|
Definition
Lidocaine (Xylocaine®)
Mexiletine (Mexitil®)
Tocainide (Tonocard®) |
|
|
Term
|
Definition
Xylocaine®
Used primarily for premature ventricular contractions and ventricular arrhythmias, originally used as a local anesthetic
Class IB |
|
|
Term
|
Definition
Mexitil®
Used as long term prophylaxis against ventricular tachycardia
Available as an oral formulation
Class IB |
|
|
Term
|
Definition
Tonocard®
Used chronically, available as an oral formulation
Class IB |
|
|
Term
|
Definition
MOA: Block fast acting sodium channels, dissociate slowly from the sodium channels, therefore are the most potent
|
|
|
Term
|
Definition
Flecainide (Tambocor®)
Propafenone (Rythmol®)
|
|
|
Term
|
Definition
Tambocor®
Good for suppressing ventricular automaticity by slowing AV conduction
Has local anesthetic activity
Class IC |
|
|
Term
|
Definition
Rythmol®
Used for supraventricular arrhythmias
Orally active, has weak beta blocking activity
Class IC |
|
|
Term
|
Definition
Beta Blockers
MOA: Stabilizes or depresses the membrane through inhibition of adrenergic stimulation to the heart, slows the heart rate and ectopic tachycardias |
|
|
Term
|
Definition
Propranolol (Inderal®)
Esmolol (Brevibloc®)
Acebutolol (Sectral®) |
|
|
Term
|
Definition
Inderal®
Used for the treatment of supraventricular arrhythmias and ventricular tachycardias
Major metabolite: Napthoxylactic acid
Class II |
|
|
Term
|
Definition
Brevibloc®
Used for inoperative and other arrhythmias
Short acting, IV only
Class II |
|
|
Term
|
Definition
Sectral®
Used for premature ventricular contractions and ventricular tachycardia
Active metabolite: diacetolol
Class II |
|
|
Term
|
Definition
Repolarization Prolongators
MOA: Prolong action potential thus increasing the refractory period of the membrane action potential. May also block potassium and sodium channels |
|
|
Term
|
Definition
Amiodarone (Cordarone®)
Dronedarone (Multaq®)
Sotalol (Betapace®)
Ibutilide (Covert®)
Dofetilide (Tikosyn®) |
|
|
Term
|
Definition
Cordarone®
Used to control refractory ventricular tachycardias, prevent ventricular fibrillation, and atrial fibrillation (non-FDA)
SE: Pulmonary toxicity, thyroid toxicity, interstitial fibrosis, phototoxicity, optic neuritis
Class III |
|
|
Term
|
Definition
Multaq®
Used for persistent atrial fibrillation and atrial flutter
SE: Less pulmonary side effects, thyroid effects, and neurological activity than Amiodarone
Class III |
|
|
Term
|
Definition
Betapace®
Used for ventricular arrhythmias and atrial fibrillation
Available orally
Class III |
|
|
Term
|
Definition
Corvert®
Blocks potassium channel and /or slow sodium channels
Used to convert atrial fibrillation and atrial flutter to normal sinus rhythm
SE: Torsade de pointe
Class III |
|
|
Term
|
Definition
Tikosyn®
Used for the conversion and management of atrial flutter to normal sinus rhythm
SE: Torsade de pointe
Class III |
|
|
Term
|
Definition
Calcium Channel Blockers
MOA: These block slow inward current of Ca2+ ions during phase 2 of action potential, Slow down AV conduction and the sinus rate
SE: Bradycardia, hypotension, headache, edema
Class IV |
|
|
Term
|
Definition
Verapamil (Calan®, Isoptin®)
Diltiazem (Cardizem®, Dilacor®)
|
|
|
Term
|
Definition
Calan®, Isoptin®
Used to control atrial and paroxysmal tachycardia
Class IV |
|
|
Term
|
Definition
Cardizem®, Dilacor®
Used to control atrial and paroxysmal tachycardia
Class IV |
|
|
Term
Miscellaneous Antiarrhythmics |
|
Definition
Adenosine (Adenocard®)
Magnesium Sulfate
Potassium |
|
|
Term
|
Definition
Adenocard®
MOA: Activates inward rectifier potassium; blocks calcium current
Nucleoside that occurs naturally in the body
Miscellaneous |
|
|
Term
|
Definition
No Brand Name
MOA: Poorly understood; interacts with Na+, K+ ATPase, K+ and Ca2+ channels
Miscellaneous |
|
|
Term
|
Definition
No Specific Brand Name
MOA: Increases K+ permeability, K+ currents
Miscellaneous |
|
|